Maurits Brandt

Verified profile

Venture Capital · Netherlands

Maurits Brandt is a venture capital investor based in the Netherlands. They invest in Health Care, Genetics, Design and Chemical. Their portfolio includes ProtAffin Biotechnologie, F-star Biotechnology, Orphazyme and Affectis Pharmaceuticals and 8 other companies.

Industries

Portfolio companies (12)

  • ProtAffin Biotechnologie
  • F-star Biotechnology
  • Orphazyme
  • Affectis Pharmaceuticals
  • Aquapharm Biodiscovery
  • to-BBB
  • i-Optics
  • EOS (Ethical Oncology Science)
  • Avantium Technologies
  • Biocartis
  • ActoGeniX
  • Vivendy Therapeutics

Similar investors in Health Care

  • Boyd RuttenVerified

    Venture Capital, Private Equity Firm · Netherlands

    Health CareWearablesHospitalsWellness

    Portfolio: Santaris Pharma, Noema Pharma

    Contact details available

  • Pieter de Jong

    Private Equity Firm · Netherlands

    Health CareWearablesE-commerceLeisure

    Portfolio: Everis Group, Carbonite

    Contact details available

  • Bart Hoeflaak

    Venture Capital · Netherlands

    Health CareE-commerceConsumer GoodsSearch Engine Optimization (SEO)

    Portfolio: Textmetrics, Pepscope

    Contact details available

  • Peter van Gelderen

    Venture Capital, Corporate Venture Capital · Netherlands

    Pollution ControlHealth CareConsumer GoodsEnergy

    Portfolio: Innosolids, Squirro

    Contact details available

  • Pieter Rhemrev

    Venture Capital · Netherlands

    Health CareE-commerceConsumer GoodsSearch Engine Optimization (SEO)

    Portfolio: Textmetrics, Pepscope

    Contact details available

  • Sander Verbrugge

    Venture Capital, Private Equity Firm · Netherlands

    Health CareCommercialTelecommunicationsHospitals

    Portfolio: FUMI Ingredients, Axign

    Contact details available

  • Ronald KemmerenVerified

    Venture Capital, Private Equity Firm · Netherlands

    Health CareWearablesEvents ServicesPayments

    Portfolio: Cotesa, Airborne Technology

    Contact details available

  • Rogier Rooswinkel

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma

    Contact details available